Literature DB >> 24530297

Influence of age and gender on lipid accumulation product and its relation to diabetes mellitus in Japanese.

Ichiro Wakabayashi1.   

Abstract

BACKGROUND: Lipid accumulation product (LAP) is a recently proposed good discriminator for cardiovascular disease and diabetes. The aim of this study was to clarify how age and gender influence LAP and its relation to diabetes.
METHODS: Subjects (18,793 women and 35,684 men) were divided by age into 4 groups of 35-39 years, 40-49 years, 50-59 years, and 60-70 years. LAP was compared among the age groups and between women and men.
RESULTS: In women, LAP tended to be higher with an increase in age after 35-39 years, while LAP in men was highest in the middle-aged group (40-49 years) and declined after 50 years. LAP was lower in women than in men in the younger groups and was higher in women than in men in the oldest group. The odds ratio for diabetes of subjects with vs. those without high LAP levels was significantly higher than the reference level of 1.00 and tended to be higher in women than in men and to be lower with an increase in age both in women and men.
CONCLUSION: LAP and its association with diabetes are influenced by both age and gender.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aging; Diabetes mellitus; Gender; Lipid accumulation product; Visceral obesity

Mesh:

Substances:

Year:  2014        PMID: 24530297     DOI: 10.1016/j.cca.2014.02.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  The effect of lipid accumulation product and its interaction with other factors on hypertension risk in Chinese Han population: A cross-sectional study.

Authors:  Jian Song; Yingying Zhao; Sumei Nie; Xue Chen; Xuesen Wu; Jing Mi
Journal:  PLoS One       Date:  2018-06-06       Impact factor: 3.240

2.  Risk factors for prehypertension and their interactive effect: a cross- sectional survey in China.

Authors:  Jian Song; Xue Chen; Yingying Zhao; Jing Mi; Xuesen Wu; Huaiquan Gao
Journal:  BMC Cardiovasc Disord       Date:  2018-09-15       Impact factor: 2.298

3.  Estimate of prevalent diabetes from cardiometabolic index in general Chinese population: a community-based study.

Authors:  Wen-Rui Shi; Hao-Yu Wang; Shuang Chen; Xiao-Fan Guo; Zhao Li; Ying-Xian Sun
Journal:  Lipids Health Dis       Date:  2018-10-12       Impact factor: 3.876

4.  Association of lipid accumulation product trajectories with 5-year incidence of type 2 diabetes in Chinese adults: a cohort study.

Authors:  Guangyu Yan; Fei Li; Christelle Elia; Yating Zhao; Jiangguang Wang; Zhiheng Chen; Hong Yuan; Yao Lu
Journal:  Nutr Metab (Lond)       Date:  2019-10-21       Impact factor: 4.169

5.  Association and Interaction Analysis of Lipid Accumulation Product with Impaired Fasting Glucose Risk: A Cross-Sectional Survey.

Authors:  Jian Song; Xue Chen; Yuhong Jiang; Jing Mi; Yuyuan Zhang; Yingying Zhao; Xuesen Wu; Huaiquan Gao
Journal:  J Diabetes Res       Date:  2019-10-28       Impact factor: 4.011

6.  Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids.

Authors:  Tomohiro Yamada; Makoto Horikawa; Tomohito Sato; Tomoaki Kahyo; Yusuke Takanashi; Hiroki Ushirozako; Kenta Kurosu; Md Al Mamun; Yuki Mihara; Shin Oe; Hideyuki Arima; Tomohiro Banno; Go Yosida; Tomohiko Hasegawa; Yu Yamato; Yukihiro Matsuyama; Mitsutoshi Setou
Journal:  Sci Rep       Date:  2021-12-06       Impact factor: 4.379

7.  Age-adjusted cut-off values of lipid accumulation product (LAP) for predicting hypertension.

Authors:  Anastasiya M Kaneva; Evgeny R Bojko
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

8.  Comparison of lipid accumulation product and body mass index as indicators of diabetes diagnosis among 215,651 Chinese adults.

Authors:  Tian Tian; Hualian Pei; Zhen Chen; Gulisiya Hailili; Shuxia Wang; Yong Sun; Hua Yao; Dai Jianghong
Journal:  PeerJ       Date:  2020-02-10       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.